• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

以腔内MRI引导活检为参考标准时,前列腺MRI的欧洲泌尿生殖放射学会(ESUR)评分的阅片者间一致性。

Inter-reader agreement of the ESUR score for prostate MRI using in-bore MRI-guided biopsies as the reference standard.

作者信息

Schimmöller L, Quentin M, Arsov C, Lanzman R S, Hiester A, Rabenalt R, Antoch G, Albers P, Blondin D

机构信息

Medical Faculty, Department of Diagnostic and Interventional Radiology, University Dusseldorf, Moorenstr. 5, 40225, Dusseldorf, Germany.

出版信息

Eur Radiol. 2013 Nov;23(11):3185-90. doi: 10.1007/s00330-013-2922-y. Epub 2013 Jun 12.

DOI:10.1007/s00330-013-2922-y
PMID:23756958
Abstract

OBJECTIVES

The recent European Society of Urogenital Radiology (ESUR) guidelines for evaluation and reporting of prostate multiparametric magnetic resonance imaging (mp-MRI) include the Prostate Imaging Reporting and Data System (PI-RADS). The aim of this study was to investigate the inter-reader agreement of this scoring system.

METHODS

One hundred and sixty-four lesions in 67 consecutive patients with elevated prostate-specific antigen and previously negative trans-rectal ultrasound (TRUS)-guided biopsy were scored retrospectively by three blinded readers using PI-RADS. Mp-MRI was performed at 3 T using T2-weighted, diffusion-weighted and dynamic contrast-enhanced imagings (T2WI, DWI, DCE-MRI). Histology of all lesions was obtained by in-bore MRI-guided biopsy. Cohen's kappa statistics were calculated for all readers.

RESULTS

Inter-reader agreement for all lesions was good to moderate (T2WI, κ = 0.55; DWI, κ = 0.64; DCE-MRI, κ = 0.65). For tumour lesions it was good (T2WI, κ = 0.66; DWI, κ = 0.80; DCE-MRI, κ = 0.63) and for benign lesions moderate to good (T2WI, κ = 0.46; DWI, κ = 0.52; DCE-MRI, κ = 0.67). Using an overall PI-RADS score with a threshold of ≥10, we achieved a sensitivity of 85.7 %, and negative predictive value of 90.1 % for biopsied lesions.

CONCLUSION

PI-RADS score shows good to moderate inter-reader agreement and enables standardised evaluation of prostate mp-MRI, with high sensitivity and negative predictive value.

KEY POINTS

• The European Society of Urogenital Radiology recently published guidelines for prostate MRI. • We have evaluated inter-reader agreement of ESUR scoring for multiparametric prostate MRI. • PI-RADS shows good to moderate inter-reader agreement and is clinically applicable. • PI-RADS achieves in our series high sensitivity and negative predictive value for biopsied lesions. • PI-RADS can be used as standardised scoring system in prostate cancer detection.

摘要

目的

欧洲泌尿生殖放射学会(ESUR)近期发布的前列腺多参数磁共振成像(mp-MRI)评估与报告指南纳入了前列腺影像报告和数据系统(PI-RADS)。本研究旨在调查该评分系统在不同阅片者之间的一致性。

方法

对67例前列腺特异性抗原升高且经直肠超声(TRUS)引导下活检先前结果为阴性的连续患者的164个病灶,由三名不知情的阅片者采用PI-RADS进行回顾性评分。mp-MRI在3T条件下进行,采用T2加权、扩散加权和动态对比增强成像(T2WI、DWI、DCE-MRI)。所有病灶的组织学结果通过磁共振引导下活检获得。计算所有阅片者的Cohen's kappa统计量。

结果

所有病灶在不同阅片者之间的一致性为中等至良好(T2WI,κ = 0.55;DWI,κ = 0.64;DCE-MRI,κ = 0.65)。对于肿瘤性病灶,一致性良好(T2WI,κ = 0.66;DWI,κ = 0.80;DCE-MRI,κ = 0.63),对于良性病灶,一致性为中等至良好(T2WI,κ = 0.46;DWI,κ = 0.52;DCE-MRI,κ = 0.67)。使用总体PI-RADS评分阈值≥10时,活检病灶的敏感性为85.7%,阴性预测值为90.1%。

结论

PI-RADS评分在不同阅片者之间的一致性为中等至良好,能够对前列腺mp-MRI进行标准化评估,具有高敏感性和阴性预测值。

关键点

• 欧洲泌尿生殖放射学会近期发布了前列腺MRI指南。• 我们评估了ESUR对多参数前列腺MRI评分在不同阅片者之间的一致性。• PI-RADS在不同阅片者之间的一致性为中等至良好,具有临床适用性。• 在我们的研究系列中,PI-RADS对活检病灶具有高敏感性和阴性预测值。• PI-RADS可作为前列腺癌检测的标准化评分系统。

相似文献

1
Inter-reader agreement of the ESUR score for prostate MRI using in-bore MRI-guided biopsies as the reference standard.以腔内MRI引导活检为参考标准时,前列腺MRI的欧洲泌尿生殖放射学会(ESUR)评分的阅片者间一致性。
Eur Radiol. 2013 Nov;23(11):3185-90. doi: 10.1007/s00330-013-2922-y. Epub 2013 Jun 12.
2
MR-sequences for prostate cancer diagnostics: validation based on the PI-RADS scoring system and targeted MR-guided in-bore biopsy.用于前列腺癌诊断的磁共振序列:基于PI-RADS评分系统及靶向磁共振引导下穿刺活检的验证
Eur Radiol. 2014 Oct;24(10):2582-9. doi: 10.1007/s00330-014-3276-9. Epub 2014 Jun 28.
3
Evaluation of the prostate imaging reporting and data system for the detection of prostate cancer by the results of targeted biopsy of the prostate.前列腺影像报告和数据系统在前列腺靶向活检检测前列腺癌中的应用评价。
Invest Radiol. 2014 Jun;49(6):411-20. doi: 10.1097/RLI.0000000000000030.
4
Prospective comparison of a fast 1.5-T biparametric with the 3.0-T multiparametric ESUR magnetic resonance imaging protocol as a triage test for men at risk of prostate cancer.前瞻性比较 1.5-T 双参数快速与 3.0-T 多参数 ESUR 磁共振成像方案作为前列腺癌风险男性的分诊试验。
BJU Int. 2019 Mar;123(3):411-420. doi: 10.1111/bju.14538. Epub 2018 Oct 19.
5
Evaluation of the ESUR PI-RADS scoring system for multiparametric MRI of the prostate with targeted MR/TRUS fusion-guided biopsy at 3.0 Tesla.在3.0特斯拉场强下,采用靶向磁共振/超声融合引导活检对前列腺多参数磁共振成像的欧洲泌尿生殖放射学会前列腺影像报告和数据系统(ESUR PI-RADS)评分系统进行评估。
Eur Radiol. 2014 Feb;24(2):344-52. doi: 10.1007/s00330-013-3017-5. Epub 2013 Oct 3.
6
Multiparametric MRI in detection and staging of prostate cancer.多参数磁共振成像在前列腺癌检测与分期中的应用
Dan Med J. 2017 Feb;64(2).
7
Comparison of PI-RADS v1 and v2 for multiparametric MRI detection of prostate cancer with whole-mount histological workup as reference standard.PI-RADS v1 与 v2 对全组织切片病理检查作为参考标准的多参数 MRI 前列腺癌检测的比较。
Eur J Radiol. 2019 Jul;116:180-185. doi: 10.1016/j.ejrad.2019.04.012. Epub 2019 May 14.
8
Comparison of PI-RADS version 2 and PI-RADS version 2.1 for the detection of transition zone prostate cancer.PI-RADS 版本 2 与 PI-RADS 版本 2.1 对移行区前列腺癌检测的比较。
Eur J Radiol. 2019 Dec;121:108704. doi: 10.1016/j.ejrad.2019.108704. Epub 2019 Oct 17.
9
Comparison of Biparametric and Multiparametric MRI for Clinically Significant Prostate Cancer Detection With PI-RADS Version 2.1.基于PI-RADS v2.1的双参数和多参数MRI在检测临床显著性前列腺癌中的比较
J Magn Reson Imaging. 2021 Jan;53(1):283-291. doi: 10.1002/jmri.27283. Epub 2020 Jul 2.
10
Assessment of PI-RADS v2 for the Detection of Prostate Cancer.前列腺影像报告和数据系统(PI-RADS)v2版在前列腺癌检测中的评估
Eur J Radiol. 2016 Apr;85(4):726-31. doi: 10.1016/j.ejrad.2016.01.011. Epub 2016 Jan 19.

引用本文的文献

1
Prostate Cancer Detection with mpMRI According to PI-RADS v2 Compared with Systematic MRI/TRUS-Fusion Biopsy: A Prospective Study.基于 PI-RADS v2 的 mpMRI 对前列腺癌的检测与系统 MRI/TRUS-融合活检的比较:一项前瞻性研究。
Tomography. 2022 Aug 16;8(4):2020-2029. doi: 10.3390/tomography8040169.
2
Evaluating the performance of clinical and radiological data in predicting prostate cancer in prostate imaging reporting and data system version 2.1 category 3 lesions of the peripheral and the transition zones.评估临床和影像学数据在预测前列腺影像报告和数据系统 2.1 版外周带和移行带 3 类病变前列腺癌中的表现。
Int Urol Nephrol. 2022 Feb;54(2):263-271. doi: 10.1007/s11255-021-03071-7. Epub 2021 Nov 25.
3

本文引用的文献

1
Differentiation of transitional zone prostate cancer from benign hyperplasia nodules: evaluation of discriminant criteria at multiparametric MRI.移行区前列腺癌与良性增生结节的鉴别诊断:多参数 MRI 鉴别标准评估。
Clin Radiol. 2013 Jun;68(6):e323-30. doi: 10.1016/j.crad.2013.01.018. Epub 2013 Mar 23.
2
Influence of imaging and histological factors on prostate cancer detection and localisation on multiparametric MRI: a prospective study.影像学和组织学因素对多参数 MRI 前列腺癌检测和定位的影响:一项前瞻性研究。
Eur Radiol. 2013 Jul;23(7):2019-29. doi: 10.1007/s00330-013-2795-0. Epub 2013 Mar 15.
3
Prostate cancer aggressiveness: in vivo assessment of MR spectroscopy and diffusion-weighted imaging at 3 T.
Inter-reader agreement of the PI-QUAL score for prostate MRI quality in the NeuroSAFE PROOF trial.
NeuroSAFE PROOF 试验中前列腺 MRI 质量的 PI-QUAL 评分的读者间一致性。
Eur Radiol. 2022 Feb;32(2):879-889. doi: 10.1007/s00330-021-08169-1. Epub 2021 Jul 29.
4
Test-retest repeatability of a deep learning architecture in detecting and segmenting clinically significant prostate cancer on apparent diffusion coefficient (ADC) maps.基于表观扩散系数(ADC)图检测和分割临床上有意义的前列腺癌的深度学习架构的复测重复性。
Eur Radiol. 2021 Jan;31(1):379-391. doi: 10.1007/s00330-020-07065-4. Epub 2020 Jul 23.
5
Factors Influencing Variability in the Performance of Multiparametric Magnetic Resonance Imaging in Detecting Clinically Significant Prostate Cancer: A Systematic Literature Review.影响多参数磁共振成像检测临床显著前列腺癌性能变异性的因素:系统文献回顾。
Eur Urol Oncol. 2020 Apr;3(2):145-167. doi: 10.1016/j.euo.2020.02.005. Epub 2020 Mar 17.
6
Radiological semantics discriminate clinically significant grade prostate cancer.放射学术语义可区分临床显著分级前列腺癌。
Cancer Imaging. 2019 Dec 3;19(1):81. doi: 10.1186/s40644-019-0272-y.
7
Intra- and interreader reproducibility of PI-RADSv2: A multireader study.PI-RADSv2 的同读和异读重复性:一项多读者研究。
J Magn Reson Imaging. 2019 Jun;49(6):1694-1703. doi: 10.1002/jmri.26555. Epub 2018 Dec 21.
8
Simplified Luminal Water Imaging for the Detection of Prostate Cancer From Multiecho T MR Images.基于多回波 T1 加权磁共振成像的简化管腔水成像检测前列腺癌。
J Magn Reson Imaging. 2019 Sep;50(3):910-917. doi: 10.1002/jmri.26608. Epub 2018 Dec 19.
9
Detection rate of clinically significant prostate cancer in magnetic resonance imaging and ultrasonography-fusion transperineal targeted biopsy for lesions with a prostate imaging reporting and data system version 2 score of 3-5.前列腺影像报告和数据系统第2版评分为3 - 5分的病变在磁共振成像和超声融合经会阴靶向活检中临床显著前列腺癌的检出率
Int J Urol. 2019 Feb;26(2):217-222. doi: 10.1111/iju.13842. Epub 2018 Nov 21.
10
Comparison of the Prostate Imaging Reporting and Data System (PI-RADS) Version 1 and 2 in a Cohort of 245 Patients with Histopathological Reference and Long-Term Follow-Up.在245例有组织病理学参考及长期随访的患者队列中对前列腺影像报告和数据系统(PI-RADS)第1版和第2版进行比较。
J Belg Soc Radiol. 2016 Nov 24;100(1):108. doi: 10.5334/jbr-btr.1147.
前列腺癌侵袭性:3T 时磁共振波谱和弥散加权成像的体内评估。
Radiology. 2012 Nov;265(2):457-67. doi: 10.1148/radiol.12111744. Epub 2012 Jul 27.
4
Inter-reader agreement of multi-parametric MR imaging for the detection of prostate cancer: evaluation of a scoring system.多参数磁共振成像检测前列腺癌的阅片者间一致性:一种评分系统的评估
Rofo. 2012 Oct;184(10):925-9. doi: 10.1055/s-0032-1312876. Epub 2012 Jun 28.
5
[Standardised scoring of a multi-parametric 3-T MRI for a targeted MRI-guided prostate biopsy].[用于靶向MRI引导下前列腺穿刺活检的多参数3-T MRI标准化评分]
Urologe A. 2012 Jun;51(6):848-56. doi: 10.1007/s00120-012-2825-6.
6
Repeat transrectal ultrasound biopsies with additional targeted cores according to results of functional prostate MRI detects high-risk prostate cancer in patients with previous negative biopsy and increased PSA - a pilot study.根据功能前列腺 MRI 的结果,对先前阴性活检和 PSA 升高的患者进行重复经直肠超声活检和额外靶向核心检测,可发现高危前列腺癌——一项试点研究。
Anticancer Res. 2012 Mar;32(3):1087-92.
7
ESUR prostate MR guidelines 2012.ESUR 前列腺磁共振成像指南 2012.
Eur Radiol. 2012 Apr;22(4):746-57. doi: 10.1007/s00330-011-2377-y. Epub 2012 Feb 10.
8
Prostate cancer: multiparametric MR imaging for detection, localization, and staging.前列腺癌:多参数磁共振成像的检测、定位和分期。
Radiology. 2011 Oct;261(1):46-66. doi: 10.1148/radiol.11091822.
9
MRI-guided prostate biopsy detects clinically significant cancer: analysis of a cohort of 100 patients after previous negative TRUS biopsy.MRI 引导下前列腺活检检测到临床显著的癌症:对先前经直肠超声活检阴性的 100 例患者队列的分析。
World J Urol. 2012 Apr;30(2):213-8. doi: 10.1007/s00345-011-0675-2. Epub 2011 Apr 22.
10
Areas suspicious for prostate cancer: MR-guided biopsy in patients with at least one transrectal US-guided biopsy with a negative finding--multiparametric MR imaging for detection and biopsy planning.可疑前列腺癌区域:至少进行过一次经直肠超声引导下前列腺活检且结果为阴性的患者——多参数磁共振成像用于检测和活检规划。
Radiology. 2011 Apr;259(1):162-72. doi: 10.1148/radiol.10101251. Epub 2011 Jan 13.